Clinical Trial Update: Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of tipranavir in combination with low-dose ritonavir in HIV-infected children; the trial completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• Tipranavir (tipranavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2011-07-25